101623
Research payments
$4,259,071
Through program year 2025, $4,259,071 in research payments was reported against 101623, across 475 payments, paid by Iovance Biotherapeutics, Inc..
- Paid by
- Iovance Biotherapeutics, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,054,168 | 255 |
| 2024 | Research | $2,204,903 | 220 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Yazan Samhouri Pittsburgh, PA Named on 52 payments
- Jason Chesney Louisville, KY Named on 39 payments
- Benjamin Creelan Tampa, FL Named on 37 payments
- Thomas Curley Pittsburgh, PA Named on 21 payments
- Ronan Kelly Dallas, TX Named on 21 payments
- Salman Punekar New York, NY Named on 18 payments
- Ranee Mehra Baltimore, MD Named on 17 payments
- Kai He Columbus, OH Named on 16 payments
- Adam Schoenfeld New York, NY Named on 16 payments
- Ammar Sukari Detroit, MI Named on 15 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.